Eprosartan use in specific populations

Revision as of 15:31, 20 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Eprosartan}} {{CMG}}; {{AE}} {{SS}} ==Use In Specific Populations== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TEVETEN (EPROSAR...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Eprosartan
TEVETEN® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Eprosartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Use In Specific Populations

[1]

References

  1. ↑ "TEVETEN (EPROSARTAN MESYLATE) TABLET [ABBOTT LABORATORIES]". Retrieved 20 February 2014.

Template:Angiotensin II receptor antagonists

Retrieved from "https://www.wikidoc.org/index.php?title=Eprosartan_use_in_specific_populations&oldid=945613"